Skip to main content

Olmesartan medoxomil, amlodipine and hydrochlorothiazide

NDC 31722-892 · Camber Pharmaceuticals, Inc.

Generic nameOlmesartan medoxomil, amlodipine and hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE
Strength5; 12.5; 20 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

31722-892-30 — 30 TABLET, FILM COATED in 1 BOTTLE (31722-892-30)

31722-892-32 — 10 BLISTER PACK in 1 CARTON (31722-892-32) / 10 TABLET, FILM COATED in 1 BLISTER PACK (31722-892-31)

31722-892-90 — 90 TABLET, FILM COATED in 1 BOTTLE (31722-892-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-448 — Amlodipine and Olmesartan Medoxomil, 31722-755 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 31722-756 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 31722-757 — LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, 31722-852 — OLMESARTAN MEDOXOMIL, 31722-853 — OLMESARTAN MEDOXOMIL, 31722-854 — OLMESARTAN MEDOXOMIL, 31722-886 — Olmesartan medoxomil and hydrochlorothiazide, 31722-887 — Olmesartan medoxomil and hydrochlorothiazide, 31722-888 — Olmesartan medoxomil and hydrochlorothiazide, 31722-893 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-894 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-895 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-896 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 33342-050 — Losartan potassium and Hydrochlorothiazide, 33342-051 — Losartan potassium and Hydrochlorothiazide, 33342-052 — Losartan potassium and Hydrochlorothiazide, 33342-057 — Irbesartan and Hydrochlorothiazide, 33342-058 — Irbesartan and Hydrochlorothiazide, 33342-074 — Valsartan and Hydrochlorothiazide, +1450 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels